- Home
- DLHC vs PMVP Comparison
DLHC vs PMVP Comparison
Compare DLHC & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLHC
- PMVP
- Stock Information
- Founded
- DLHC 1969
- PMVP 2013
- Country
- DLHC United States
- PMVP United States
- Employees
- DLHC N/A
- PMVP N/A
- Industry
- DLHC Business Services
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- DLHC Consumer Discretionary
- PMVP Health Care
- Exchange
- DLHC Nasdaq
- PMVP Nasdaq
- Market Cap
- DLHC 80.6M
- PMVP 82.7M
- IPO Year
- DLHC N/A
- PMVP 2020
- Fundamental
- Price
- DLHC $5.59
- PMVP $1.42
- Analyst Decision
- DLHC
- PMVP Strong Buy
- Analyst Count
- DLHC 0
- PMVP 1
- Target Price
- DLHC N/A
- PMVP $5.00
- AVG Volume (30 Days)
- DLHC 10.7K
- PMVP 757.9K
- Earning Date
- DLHC 12-03-2025
- PMVP 11-07-2025
- Dividend Yield
- DLHC N/A
- PMVP N/A
- EPS Growth
- DLHC 80.25
- PMVP N/A
- EPS
- DLHC 0.31
- PMVP N/A
- Revenue
- DLHC $359,723,000.00
- PMVP N/A
- Revenue This Year
- DLHC N/A
- PMVP N/A
- Revenue Next Year
- DLHC N/A
- PMVP N/A
- P/E Ratio
- DLHC $18.54
- PMVP N/A
- Revenue Growth
- DLHC N/A
- PMVP N/A
- 52 Week Low
- DLHC $2.72
- PMVP $0.81
- 52 Week High
- DLHC $9.58
- PMVP $1.84
- Technical
- Relative Strength Index (RSI)
- DLHC 58.98
- PMVP 53.72
- Support Level
- DLHC $5.53
- PMVP $1.43
- Resistance Level
- DLHC $5.88
- PMVP $1.67
- Average True Range (ATR)
- DLHC 0.16
- PMVP 0.10
- MACD
- DLHC 0.03
- PMVP 0.01
- Stochastic Oscillator
- DLHC 70.21
- PMVP 54.07
About DLHC DLH Holdings Corp.
DLH Holdings Corp is a provider of technology-enabled business process outsourcing and program management solutions in the United States. The company offers services to several government agencies which include the Department of Veteran Affairs. The company is engaged in public health, performance evaluation, and health operations to solve the complex problems faced by civilian and military customers alike, leveraging digital transformation, artificial intelligence, analytics, cloud-based applications, telehealth systems, and others.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.